Daniele Generali

Epithelial-mesenchymal transition and breast cancer: role, molecular mechanisms and clinical impact.

Massimo Broggini, Giovanna Damia, D. Generali, 2012, Cancer treatment reviews.

Hypoxia-Inducible Factor-1α Expression Predicts a Poor Response to Primary Chemoendocrine Therapy and Disease-Free Survival in Primary Human Breast Cancer

Manuela Milani, Stephen B. Fox, Adrian L. Harris, 2006, Clinical Cancer Research.

Gene expression profiling in breast cancer: a clinical perspective.

Fabio Puglisi, Anna Sapino, A. Sapino, 2013, Breast.

Comparison of Molecular Subtyping with BluePrint, MammaPrint, and TargetPrint to Local Clinical Subtyping in Breast Cancer Patients

Bichlien Nguyen, D. Generali, K. Yao, 2012, Annals of Surgical Oncology.

The G-Protein–Coupled Receptor CLR Is Upregulated in an Autocrine Loop with Adrenomedullin in Clear Cell Renal Cell Carcinoma and Associated with Poor Prognosis

Stephen Henderson, Stephen B Fox, Adrian L Harris, 2013, Clinical Cancer Research.

Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.

Adrian L Harris, A. Harris, R. Poulsom, 2005, Cancer research.

Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.

Manuela Milani, Stephen B Fox, Adrian L Harris, 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer

Oriana Ciani, Carla Rognoni, Lajos Pusztai, 2015, Breast Cancer Research and Treatment.